Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

This acquisition combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and TriLink BioTechnologies' leading drug substance manufacturing capabilities, providing customers ...

“By integrating our expertise in mRNA design and nanoparticle delivery with IPA’s cutting-edge antibody discovery and engineering capabilities, we can address longstanding challenges in ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

The cancer vaccine candidate is manufactured with mRNA specific to these neoantigens found in that individual’s tumor. The process to design and manufacture individualized vaccines for cancer ...

CureVac developed proprietary foundational technologies over the last 25 years related to mRNA design, delivery and manufacturing, which materially contributed to the development of safe and ...

Everest Medicines has established a fully integrated and clinically validated mRNA platform, encompassing antigen design, mRNA sequence optimization, LNP delivery system, and GMP production ...